FSGS: Diagnosis and Diagnostic Work-Up.
Focal segmental glomerulosclerosis is a histologic lesion, rather than a clinical disease. FSGS is common cause of nephrotic syndrome in both adults and children worldwide. In the United States it is the most common primary glomerular disease resulting in end-stage renal disease and recent reports have suggested that its incidence might be on the rise. Currently the incidence is estimated to be 7 per million. The podocyte is the cellular target cell in FSGS and in recent years substantial insight in the pathogenesis and genetics of FSGS have accumulated. Furthermore the discovery of potential novel biomarkers to diagnose FSGS and monitor disease activity has renewed interest in this disease. In this review article we will focus on the clinical presentation and diagnosis of FSGS.
Department of Microbiology & Immunology, KU Leuven, 3000 Leuven, Belgium; Department of Nephrology, University Hospitals Leuven, 3000 Leuven, Belgium.
Ben
B
Sprangers
Department of Microbiology & Immunology, KU Leuven, 3000 Leuven, Belgium; Department of Nephrology, University Hospitals Leuven, 3000 Leuven, Belgium.
Björn
B
Meijers
Center for Glomerular Diseases, Columbia University Medical Center, New York, NY 10032, USA.
Gerald
G
Appel
D000328:Adult; D015415:Biomarkers; D002648:Child; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D009404:Nephrotic Syndrome / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D014481:United States
D015415:Biomarkers